SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 22, 16:00
562.55
0.85 (0.15%)
VOLUME 88,582
LIVE
NSE
Jul 22, 17:00
563.25
0.75 (0.13%)
VOLUME 533,494
Earnings News on Ranbaxy Laboratories
Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Ranbaxy disappoints; lower EBITDA at 6% main cause: Angel 

6.17 pm | 09 May 2014 |  Source: CNBC-TV18

EBITDA margins is something which will take sometime to be steady for Ranbaxy. It will hover around 6-8 percent range unless other core issues get res...

Ranbaxy March quarter net loss at Rs 73.6cr

3.47 pm | 09 May 2014 |  Source: PTI

During the quarter, the company recorded inventory and other costs write-off and goodwill impairment write-off of Rs 15.9 crore and Rs 43.8 crore resp...

Ranbaxy Q5 net may rise 20.5% at Rs 102.1 cr: Motilal Oswal

8.39 am | 09 May 2014 |  Source: Moneycontrol.com

Sales are expected to decrease by 5.6 percent Q-o-Q (up 11.6 percent Y-o-Y) to Rs 2730.8 crore, according to Motilal Oswal....

Pharma cos may see healthy earnings growth in Q4FY14: CLSA

12.36 pm | 03 Apr 2014 |  Source: Moneycontrol.com

Most companies are expected to report some forex gains on hedges and foreign liabilities given the slight strengthening of rupee Q-o-Q, CLSA said....

Brokerages wary about Ranbaxy sustaining its performance 

8.08 pm | 06 Feb 2014 |  Source: Moneycontrol.com

Brokerages wary about Ranbaxy sustaining its performance...

Healthy sales, operational growth push Ranbaxy 6% up: Angel 

3.25 pm | 05 Feb 2014 |  Source: CNBC-TV18

Ranbaxy Laboratories, which has been struggling for drug production due to USFDA issues, reported a net loss of Rs 159 crore for the fourth quarter (O...

Key takeaways from Ranbaxy earnings commentary

2.27 pm | 05 Feb 2014 |  Source: Moneycontrol.com

In a conference call, the company, now owned by Japanese Daiichi Sankyo, said it was committed to resolving issues with the FDA, which has now banned ...

Ranbaxy posts Q4 loss at Rs 159 cr on provision for Toansa

1.12 pm | 05 Feb 2014 |  Source: Moneycontrol.com

Total income from operations grew 6.7 percent to Rs 2,894 crore during the quarter as against Rs 2,711.2 crore in a year ago period....

Ranbaxy may post Q3 PAT at Rs 10 cr, guidance revision key

10.18 am | 05 Feb 2014 |  Source: CNBC-TV18

Analysts are worried about the guidance (Rs 13,000-13,500 crore - with no first-to-file included) after the US Food and Drug Administration (USFDA) ba...

Ranbaxy Q3 net may rise 83.5% at Rs 112cr: Motilal Oswal

10.09 am | 05 Feb 2014 |  Source: Moneycontrol.com

Sales of Ranbaxy Laboratories are expected to increase by 2.8 percent Q-o-Q (up 15.7 percent Y-o-Y) to Rs 2879.1 crore, according to Motilal Oswal....

What you can expect from Ranbaxy in Oct-Dec quarter 

9.07 am | 05 Feb 2014 |  Source: Moneycontrol.com

Ranbaxy Laboratories is expected to release its Q3 numbers today....

1
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.